These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 15385129)
41. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Li J; Yang W; Wu X Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461 [TBL] [Abstract][Full Text] [Related]
42. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome. Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344 [TBL] [Abstract][Full Text] [Related]
43. Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer? Fanfani F; Fagotti A; Ercoli A; Gallotta V; Chiantera V; Restaino S; Monterossi G; Scambia G Anticancer Res; 2015 Dec; 35(12):6951-5. PubMed ID: 26637921 [TBL] [Abstract][Full Text] [Related]
44. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer. Karam AK; Chiang JW; Fung E; Nossov V; Karlan BY Gynecol Oncol; 2009 Aug; 114(2):246-52. PubMed ID: 19500821 [TBL] [Abstract][Full Text] [Related]
45. Splenectomy and surgical cytoreduction for ovarian cancer. Chen LM; Leuchter RS; Lagasse LD; Karlan BY Gynecol Oncol; 2000 Jun; 77(3):362-8. PubMed ID: 10831343 [TBL] [Abstract][Full Text] [Related]
46. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery. Fanfani F; Fagotti A; Gallotta V; Ercoli A; Pacelli F; Costantini B; Vizzielli G; Margariti PA; Garganese G; Scambia G Gynecol Oncol; 2010 Mar; 116(3):497-501. PubMed ID: 20004958 [TBL] [Abstract][Full Text] [Related]
47. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Eisenkop SM; Spirtos NM Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145 [TBL] [Abstract][Full Text] [Related]
48. The role of secondary cytoreductive surgery for recurrent ovarian cancer. Güngör M; Ortaç F; Arvas M; Kösebay D; Sönmezer M; Köse K Gynecol Oncol; 2005 Apr; 97(1):74-9. PubMed ID: 15790440 [TBL] [Abstract][Full Text] [Related]
49. The role of cytoreductive surgery for colon cancer metastatic to the ovary. McCormick CC; Giuntoli RL; Gardner GJ; Schulick RD; Judson K; Ronnett BM; Vang R; Bristow RE Gynecol Oncol; 2007 Jun; 105(3):791-5. PubMed ID: 17408727 [TBL] [Abstract][Full Text] [Related]
50. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience. Ayhan A; Gultekin M; Taskiran C; Aksan G; Celik NY; Dursun P; Salman MC; Yuce K; Kucukali T Am J Obstet Gynecol; 2006 Jan; 194(1):49-56. PubMed ID: 16389009 [TBL] [Abstract][Full Text] [Related]
51. Intraoperative radiation therapy in recurrent ovarian cancer. Yap OW; Kapp DS; Teng NN; Husain A Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1114-21. PubMed ID: 15964710 [TBL] [Abstract][Full Text] [Related]
52. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer]. Zhao JZ; Wang G; Zhang RP; Liang H Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624 [TBL] [Abstract][Full Text] [Related]
53. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Bijelic L; Yan TD; Sugarbaker PH Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156 [TBL] [Abstract][Full Text] [Related]
54. [Results of cytoreductive surgery for advanced and recurrent ovarian neoplasms and papillary serous carcinomas of the peritoneum]. Ivanov S; Ivanov S Akush Ginekol (Sofiia); 2004; 43(5):36-8. PubMed ID: 15518283 [TBL] [Abstract][Full Text] [Related]
55. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150 [TBL] [Abstract][Full Text] [Related]
56. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. Gronlund B; Lundvall L; Christensen IJ; Knudsen JB; Høgdall C Eur J Surg Oncol; 2005 Feb; 31(1):67-73. PubMed ID: 15642428 [TBL] [Abstract][Full Text] [Related]
57. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study. Salani R; Zahurak ML; Santillan A; Giuntoli RL; Bristow RE Gynecol Oncol; 2007 Dec; 107(3):495-9. PubMed ID: 17854870 [TBL] [Abstract][Full Text] [Related]
58. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis]. Huang X; Cai SM; Tang J; Li ZT; Zang RY Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187 [TBL] [Abstract][Full Text] [Related]
59. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Helm CW; Randall-Whitis L; Martin RS; Metzinger DS; Gordinier ME; Parker LP; Edwards RP Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957 [TBL] [Abstract][Full Text] [Related]
60. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]